Cancer cells carry distinctive features that let them grow quickly and dodge normal quality controls. Rice University researcher Natasha Kirienko aims to exploit these traits for therapy. A new paper from her group describes a screening method that sifted through more than 4 million compounds to find potential leukemia drugs.
The approach relies on differences between healthy and cancerous cells, using those differences as a handle to identify molecules that might selectively harm the disease. From the massive library, the screen pulled out candidate compounds worth further investigation.
The work is still at an early stage, and the source does not specify which compounds were validated or how far they are from clinical testing. It does show that large-scale, biology-driven screening can narrow millions of options down to a manageable set of leads for leukemia.